Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Antiandrogen therapy helps treat genetic hair loss.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Ruxolitinib helped a patient with alopecia areata regrow hair.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Ritlecitinib works well and is safe for treating alopecia areata.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.